Federal judges in Delaware and New Jersey are of two minds on whether to disqualify the 650-lawyer global litigation firm Howrey from companion patent disputes among U.S. pharmaceutical giants Wyeth and Boston Scientific.

The firm can stay in the case in Delaware, but it’s out in New Jersey, the judges say, demonstrating how ethics rules morph when they cross state lines.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]